335 related articles for article (PubMed ID: 12542662)
1. Long-term striatal overexpression of GDNF selectively downregulates tyrosine hydroxylase in the intact nigrostriatal dopamine system.
Rosenblad C; Georgievska B; Kirik D
Eur J Neurosci; 2003 Jan; 17(2):260-70. PubMed ID: 12542662
[TBL] [Abstract][Full Text] [Related]
2. Aberrant sprouting and downregulation of tyrosine hydroxylase in lesioned nigrostriatal dopamine neurons induced by long-lasting overexpression of glial cell line derived neurotrophic factor in the striatum by lentiviral gene transfer.
Georgievska B; Kirik D; Björklund A
Exp Neurol; 2002 Oct; 177(2):461-74. PubMed ID: 12429192
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of glial cell line-derived neurotrophic factor using a lentiviral vector induces time- and dose-dependent downregulation of tyrosine hydroxylase in the intact nigrostriatal dopamine system.
Georgievska B; Kirik D; Björklund A
J Neurosci; 2004 Jul; 24(29):6437-45. PubMed ID: 15269253
[TBL] [Abstract][Full Text] [Related]
4. Long-term glial cell line-derived neurotrophic factor overexpression in the intact nigrostriatal system in rats leads to a decrease of dopamine and increase of tetrahydrobiopterin production.
Sajadi A; Bauer M; Thöny B; Aebischer P
J Neurochem; 2005 Jun; 93(6):1482-6. PubMed ID: 15935064
[TBL] [Abstract][Full Text] [Related]
5. Chronic intranigral administration of brain-derived neurotrophic factor produces striatal dopaminergic hypofunction in unlesioned adult rats and fails to attenuate the decline of striatal dopaminergic function following medial forebrain bundle transection.
Lapchak PA; Beck KD; Araujo DM; Irwin I; Langston JW; Hefti F
Neuroscience; 1993 Apr; 53(3):639-50. PubMed ID: 8098137
[TBL] [Abstract][Full Text] [Related]
6. Regulated delivery of glial cell line-derived neurotrophic factor into rat striatum, using a tetracycline-dependent lentiviral vector.
Georgievska B; Jakobsson J; Persson E; Ericson C; Kirik D; Lundberg C
Hum Gene Ther; 2004 Oct; 15(10):934-44. PubMed ID: 15585109
[TBL] [Abstract][Full Text] [Related]
7. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration.
Connor B; Kozlowski DA; Unnerstall JR; Elsworth JD; Tillerson JL; Schallert T; Bohn MC
Exp Neurol; 2001 May; 169(1):83-95. PubMed ID: 11312561
[TBL] [Abstract][Full Text] [Related]
8. Effect of 6-hydroxydopamine on striatal GDNF and nigral GFRalpha1 and RET mRNAs in the adult rat.
Smith AD; Antion M; Zigmond MJ; Austin MC
Brain Res Mol Brain Res; 2003 Oct; 117(2):129-38. PubMed ID: 14559146
[TBL] [Abstract][Full Text] [Related]
9. Striatal GDNF administration increases tyrosine hydroxylase phosphorylation in the rat striatum and substantia nigra.
Salvatore MF; Zhang JL; Large DM; Wilson PE; Gash CR; Thomas TC; Haycock JW; Bing G; Stanford JA; Gash DM; Gerhardt GA
J Neurochem; 2004 Jul; 90(1):245-54. PubMed ID: 15198683
[TBL] [Abstract][Full Text] [Related]
10. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model.
Rosenblad C; Kirik D; Björklund A
Exp Neurol; 2000 Feb; 161(2):503-16. PubMed ID: 10686072
[TBL] [Abstract][Full Text] [Related]
11. Striatal expression of GDNF and differential vulnerability of midbrain dopaminergic cells.
Barroso-Chinea P; Cruz-Muros I; Aymerich MS; Rodríguez-Díaz M; Afonso-Oramas D; Lanciego JL; González-Hernández T
Eur J Neurosci; 2005 Apr; 21(7):1815-27. PubMed ID: 15869477
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotection in the rat Parkinson model by intrastriatal GDNF gene transfer using a lentiviral vector.
Georgievska B; Kirik D; Rosenblad C; Lundberg C; Björklund A
Neuroreport; 2002 Jan; 13(1):75-82. PubMed ID: 11924898
[TBL] [Abstract][Full Text] [Related]
13. Long-term controlled GDNF over-expression reduces dopamine transporter activity without affecting tyrosine hydroxylase expression in the rat mesostriatal system.
Barroso-Chinea P; Cruz-Muros I; Afonso-Oramas D; Castro-Hernández J; Salas-Hernández J; Chtarto A; Luis-Ravelo D; Humbert-Claude M; Tenenbaum L; González-Hernández T
Neurobiol Dis; 2016 Apr; 88():44-54. PubMed ID: 26777664
[TBL] [Abstract][Full Text] [Related]
14. Lentivirally delivered glial cell line-derived neurotrophic factor increases the number of striatal dopaminergic neurons in primate models of nigrostriatal degeneration.
Palfi S; Leventhal L; Chu Y; Ma SY; Emborg M; Bakay R; Déglon N; Hantraye P; Aebischer P; Kordower JH
J Neurosci; 2002 Jun; 22(12):4942-54. PubMed ID: 12077191
[TBL] [Abstract][Full Text] [Related]
15. Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo.
Strömberg I; Björklund L; Johansson M; Tomac A; Collins F; Olson L; Hoffer B; Humpel C
Exp Neurol; 1993 Dec; 124(2):401-12. PubMed ID: 7904571
[TBL] [Abstract][Full Text] [Related]
16. Intranigral ventral mesencephalic grafts and nigrostriatal injections of glial cell line-derived neurotrophic factor restore dopamine release in the striatum of 6-hydroxydopamine-lesioned rats.
Tang FI; Tien LT; Zhou FC; Hoffer BJ; Wang Y
Exp Brain Res; 1998 Apr; 119(3):287-96. PubMed ID: 9551829
[TBL] [Abstract][Full Text] [Related]
17. GFR-α1 Expression in Substantia Nigra Increases Bilaterally Following Unilateral Striatal GDNF in Aged Rats and Attenuates Nigral Tyrosine Hydroxylase Loss Following 6-OHDA Nigrostriatal Lesion.
Kasanga EA; Owens CL; Cantu MA; Richard AD; Davis RW; McDivitt LM; Blancher B; Pruett BS; Tan C; Gajewski A; Manfredsson FP; Nejtek VA; Salvatore MF
ACS Chem Neurosci; 2019 Oct; 10(10):4237-4249. PubMed ID: 31538765
[TBL] [Abstract][Full Text] [Related]
18. Glial cell line-derived neurotrophic factor prevents death, but not reductions in tyrosine hydroxylase, of injured nigrostriatal neurons in adult rats.
Lu X; Hagg T
J Comp Neurol; 1997 Nov; 388(3):484-94. PubMed ID: 9368855
[TBL] [Abstract][Full Text] [Related]
19. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.
Zheng JS; Tang LL; Zheng SS; Zhan RY; Zhou YQ; Goudreau J; Kaufman D; Chen AF
Brain Res Mol Brain Res; 2005 Mar; 134(1):155-61. PubMed ID: 15790539
[TBL] [Abstract][Full Text] [Related]
20. Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle.
Rosenblad C; Kirik D; Devaux B; Moffat B; Phillips HS; Björklund A
Eur J Neurosci; 1999 May; 11(5):1554-66. PubMed ID: 10215908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
